Rosemary Jose is Director and Commercial Lead for the Strategic Market Access Center of Excellence, and is based out of the Rotterdam office, the Netherlands. Her main areas of focus are business development, payer value communication, payer/HTA landscape assessments, recent trends in EUnetHTA and HTA policy, market access insights into clinical trials and observational studies, HEOR evidence generation plans, value dossiers, payer objection handlers, HTA newsletters, strategic workshops and advisory boards.
Rosemary has >12 years of experience across the pharmaceutical industry, including >10 years in market access and health economics, both in global and consulting roles – leading strategic projects, managing international clients and mentoring multi-cultural teams. She has also provided on-site support to pharmaceutical clients in Europe, driving the market access strategy through cross-functional collaboration, to facilitate reimbursement. Her experience covers multiple therapeutic areas including oncology, neurosciences, ophthalmology, infections and immunology, gastroenterology and cardiovascular medicine. Rosemary holds a PhD in Pharmacogenetics from JIPMER, India, a Certification in HTA and Market Access from the Galbraith Wight Business School, the UK., and a Postgraduate Certificate in Health Economics from the University of Aberdeen, the UK.